Towards Healthcare
Infectious Disease Testing Market Captures USD 49.74 Bn by 2034

Infectious Disease Testing Market Dynamics, Trends, AI Integration and Companies

Based on market forecasts, the global infectious disease testing market, projected at USD 27.33 billion in 2024, is expected to reach USD 49.74 billion by 2034, growing at a CAGR of 6.24% over the forecast period. The infectious disease testing market is expanding due to increasing infectious diseases as well as growing homecare testing. North America led the market due to the presence of a well-developed healthcare sector.

Category: Diagnostics Insight Code: 5648 Format: PDF / PPT / Excel

Infectious Disease Testing Market Size, Key Players, Growth Factors and Challenges

The global infectious disease testing market size is calculated at USD 27.33 in 2024, grew to USD 29.03 billion in 2025, and is projected to reach around USD 49.74 billion by 2034. The market is expanding at a CAGR of 6.24% between 2025 and 2034.

Infectious Disease Testing Market Size 2024 - 2034

Key Takeaways

  • Infectious disease testing market to cross USD 27.33 billion in 2024.
  • Market projected at USD 49.74 billion by 2034.
  • CAGR of 6.24% expected in between 2025 to 2034.
  • North America dominated the global infectious disease testing market share in 2024.
  • Asia Pacific is expected to be the fastest-growing during the forecast period.
  • By product & services type, the kits & reagents segment dominated the market in 2024.
  • By product & services type, the software segment is estimated to be the fastest growing at a notable CAGR during the forecast period.
  • By technology type, the DNA sequencing & NGS segment dominated the market in 2024.
  • By technology type, the PCR segment is anticipated to be the fastest growing during the forecast period.
  • By end user, the hospitals/ clinical laboratories segment dominated the global infectious disease testing market in 2024.
  • By end user, the academic research institutes segment is predicted to be the fastest growing during the forecast period.

Key Metrics and Overview

Metric Details
Market Size in 2025 USD 29.03 Billion
Projected Market Size in 2034 USD 49.74 Billion
CAGR (2025 - 2034) 6.24%
Leading Region North America
Market Segmentation By Product & Services, By Technology, By End User, By Region
Top Key Players Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Becton, Thermo Fisher Scientific, Biomérieux SA, Luminex, Diasorin, Roche Diagnostics, Dickinson and Company, Quidel, Meridian Bioscience, Siemens AG

Market Overview

Infectious diseases can be caused by parasites, bacteria, and viruses, which can lead to rapid transmission and infection in humans as well as animals. Thus, for the control of these infections, various testing methods are being developed for their early diagnosis, isolation, and treatment. At the same time, new advancements for obtaining fast and accurate results are also being developed. Furthermore, to produce miniaturized, portable, and low-cost POC testing kits, materials science, microfluidics, nanotechnology, and micro-electro-mechanical systems (MEMS) technology are also being used. Thus, this enhances the speed, sensitivity, specificity, and efficiency of the tests.

  • In May 2025, a collaboration between the University of Hyderabad (UoH) and Krismo Biosciences Private Limited was recently announced. Their main goal is to develop next-generation therapies for serious infectious conditions and inflammatory diseases. (Source - THE HINDU)
  • In May 2025, a partnership between Dr Tan Chee Wah of the microbiology and immunology department at the NUS Yong Loo Lin School of Medicine (NUS Medicine) and Professor Wang Linfa of the emerging infectious diseases programme at Duke-NUS Medical School developed a test kit to tackle the next pandemic. It is based on cPass, which detects the presence of antibodies that neutralise SARS-CoV-2. (Source - The Straits Times)

How can AI Improve Infectious Disease Testing?

Artificial intelligence (AI), as well as machine learning algorithms, can help in various processes to improve infectious disease testing. They help to identify the disease pattern, which can be further integrated with environmental factors, social behavior, and genomic information for predicting the infection outbreaks. At the same time, they also identify the infection and mortality rates, which can be used in predicting the spread and severity of the infections. Thus, all these factors improve the accuracy, speed, and multi-faceted analytical approach compared to the traditional methods.

Market Dynamics

Driver

Rising Infectious Diseases

There is a rise in infectious diseases with the rising population. At the same time, the increasing awareness about the early detection of these diseases is also rising within the population. Therefore, this in turn increases the demand for the use of early and fast testing approaches. This helps in the early identification of the causative agents, which in turn helps in delivering effective treatment strategies. Furthermore, various rapid diagnostics kits are also being used for the diagnosis and management of these diseases. Thus, all these factors drive the infectious disease testing market growth.

Total No. of Infectious Disease Cases Reported in 2024

The graph represents the total number of infectious disease cases reported in year of 2024. It indicates that different types of infectious diseases are rising. Hence, it increases the demand for new infectious disease testing options for the effective management of these diseases. Thus, this in turn will ultimately promote the market growth. (Source - GOV.UK)

Restraint

Inaccurate Diagnosis

The results obtained from the testing may lead to misdiagnosis, resulting in inaccurate disease testing. Similarly, the false positive results can lead to unnecessary treatment, or the false negative results can lead to progression of the disease without any treatment. This increases the dissatisfaction among the patients.

Opportunity

Rising Homecare Testing

The demand for the use of homecare testing is rising due to increasing chronic diseases, as well as geriatric patients. Therefore, by using these testing kits at home, patients can monitor and manage their health conditions. Furthermore, it also helps in reducing the number of hospital visits, which in turn, increases patient comfort. At the same time, various new advancements are also being made with the help of software for developing digital health platforms. Thus, all these factors promote the infectious disease testing market growth.

For instance,

  • In May 2025, an initiative that involved at-home testing was renewed by the Alabama Department of Public Health (ADPH) for early detection and treatment of HIV and other STIs. (Source - WAAY 31 abc)

Segmental Insights

Kits & Reagents Segment Dominated in 2024

By product & services type, the kits & reagents segment dominated the market in 2024. The kits & reagents were used continuously in the development of various testing kits for different diseases. This contributed to the infectious disease testing market growth.

Software Segment: Fastest Growing

By product & services type, the software segment is estimated to be the fastest growing at a notable CAGR during the forecast period. The use of software is improving the accuracy as well as utilizing various other features, which help in enhancing the testing procedure.

DNA Sequencing & NGS Segment Led in 2024

By technology type, the DNA sequencing & NGS segment dominated the market in 2024. The DNA sequencing & NGS helped in the detection of various causative agents with rapid results. This enhanced the market growth.

PCR Segment: Fastest Growing

By technology type, the PCR segment is anticipated to be the fastest growing during the forecast period. The PCR testing can also be used for smaller quantities of sample testing with fast and accurate results.

Hospitals/ Clinical Laboratories Segment Dominated

By end user, the hospitals/ clinical laboratories segment dominated the global infectious disease testing market in 2024. The hospitals/ clinical laboratories tested a large number of patients. At the same time, various new testing kits were also utilized. Thus, this promoted the market growth.

Academic Research Institutes Segment: Fastest Growing

By end user, the academic research institutes segment is predicted to be the fastest growing during the forecast period. The academic research institutes are contributing to the rising research and development of various testing kits, along with AI integration.

Well-Developed Healthcare Drives North America

North America dominated the infectious disease testing market in 2024. North America consisted of well-established healthcare sectors along with the presence of advanced technologies. This increased the use and production of infectious disease testing among the population. Thus, this contributed to the market growth.

The U.S. Infectious Disease Testing Market Trends

Due to advanced hospitals and industries, the demand for the use of rapid diagnostic approaches is increasing for the early detection of infectious diseases. At the same time, with the use of AI, new testing kits are also being developed.

The Canada Infectious Disease Testing Market Trends

The industries in Canada are developing as well as increasing the manufacturing of testing kits due to rising demand. Furthermore, at-home testing is also contributing to the same, increasing their production rates.

Growing Diseases Boost Asia Pacific

Asia Pacific is estimated to host the fastest-growing infectious disease testing market during the forecast period. Asia Pacific is facing a rise in infectious diseases, which in turn is increasing the demand for infectious disease testing. This is also supported by the government, which enhances the market growth.

For instance,

  • In May 2025, a discussion for solidifying the regional institution as well as collaboration for advancing health in Asia at the World Health Summit was conducted between the Asian Collective for Health Systems (TACHS) and the Asian Development Bank (ADB). The discussion was about the rising communicable and non-communicable diseases, the impact of climatic changes, and demographic changes in South and Southeast Asia. (Source - HealthWorld.com)

The China Infectious Disease Testing Market Trends

China has a large population, due to which there is a rise in infectious disease cases. Thus, the industries as well as the hospitals are adopting various technologies for improving the testing conditions.

The India Infectious Disease Testing Market Trends

The advancing healthcare in India, along with rising infectious diseases, is utilizing as well as developing new rapid diagnostic kits for their early detection. Furthermore, to make them affordable, the government is also providing its support.

Europe Driven by Rising Innovations

Europe is expected to grow significantly in the infectious disease testing market during the forecast period. The industries and institutes in Europe are developing various new approaches for enhancing the testing of infectious diseases. This, in turn, promotes the market growth.

The Germany Infectious Disease Testing Market Trends

The research and development sectors in industries and institutes are focused on manufacturing various kits for different infection detection. Moreover, with the help of AI digital platforms for accurate testing is also being invented.

The UK Infectious Disease Testing Market Trends

In the UK, the industries as well as the institutes are collaborating to enhance the development of rapid testing kits, which can be used in hospitals as well as at home. Furthermore, they are also supported by the government and regulatory bodies.

Which are the Top Companies in the Infectious Disease Testing Market?

Infectious Disease Testing Market Companies

Latest Announcements by Industry Leaders

  • In May 2025, a microbiologist and diagnostic veteran, Dr. Camilla Rodrigues, stated that, to identify the infection, various diagnostic tests are available, which help in prescribing target antibiotics or other drugs. But still, its use is neglected, which leads to unnecessary overuse of antibiotics, which causes antibiotic resistance. This may result in 50% of deaths in the world by 2050. (Source - THE TIMES OF INDIA)
  • In May 2025, in postoperative patients to predict the risk of infection a new AI model that is PERISCOPE will be introduced. Siri van der Meijden, Ph.D. researcher, stated that with the help of PERISCOPE, it becomes easier for healthcare providers to identify patients who may require less monitoring. Furthermore, patients at risk are also identified. Thus, this will enhance the quality of life of the patients as well as minimize the impact on the healthcare services.

Recent Developments in the Infectious Disease Testing Market

  • In May 2025, Saudi Arabia opened the world's first clinic for diagnosing patients using artificial intelligence (AI). For the trial programme, Synyi AI partnered with Almoosa Health Group.
  • In May 2025, a new multiplex protein microarray was developed by Krishnamurthy HK et al., which accurately detected a variety of tick-borne infections in a single test run. It can detect both IgM and IgG antibodies against different microbes, such as Borrelia burgdorferi, the causative agent of Lyme disease. (Source - European Medical Journal)

Segments Covered in the Report

By Product & Services

  • Kits & reagents
  • Instruments
  • Software

By Technology

  • Immunodiagnostics
  • DNA Sequencing & NGS
  • PCR

By End User

  • Hospitals/Clinical Laboratories
  • Reference Laboratories
  • Physician Offices
  • Academic/Research Institutes

By Region

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden 
    • Denmark
    • Norway
  • Latin America
    • Brazil Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
       
  • Last Updated: 27 May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar, with over 14 years of experience in consumer goods, leads research at Towards Consumer Goods, ensuring precise, actionable insights on trends, consumer preferences, and sustainable packaging for businesses.

Learn more about Aditi Shivarkar

Related Reports

FAQ's

Danaher Corporation is the major player in the market.

Rising infectious diseases are the factor that drives the market growth.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.